<http://linked.opendata.cz/resource/sukl/spc/section/SPC158062_doc-4-3>	<http://salt.semanticauthoring.org/ontologies/sdo#hasText>	"Hypersenzitivita na l\u00E9\u010Divou l\u00E1tku nebo na kteroukoli pomocnou l\u00E1tku tohoto p\u0159\u00EDpravku uvedenou v bod\u011B 6.1. \nKontraindikov\u00E1no je sou\u010Dasn\u00E9 pod\u00E1v\u00E1n\u00ED inhibitor\u016F cytochromu P450 3A4, jako jsou inhibitory HIV-prote\u00E1zy, azolov\u00E1 antimykotika, erythromycin, klarithromycin a nefazodon (viz bod 4.5). \n"@cs .
<http://linked.opendata.cz/resource/sukl/spc/section/SPC158062_doc-4-3>	<http://salt.semanticauthoring.org/ontologies/sdo#hasOrderNumber>	"004.003" .
<http://linked.opendata.cz/resource/sukl/spc/section/SPC158062_doc-4-3>	<http://salt.semanticauthoring.org/ontologies/sdo#hasParagraph>	<http://linked.opendata.cz/resource/sukl/spc/paragraph/SPC158062_doc-4-3-2> .
<http://linked.opendata.cz/resource/sukl/spc/section/SPC158062_doc-4-3>	<http://salt.semanticauthoring.org/ontologies/sdo#hasSectionTitle>	"4.3 \tKontraindikace "@cs .
<http://linked.opendata.cz/resource/sukl/spc/section/SPC158062_doc-4-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://salt.semanticauthoring.org/ontologies/sdo#Section> .